WO2012120535A3 - A composition comprising highly purified chorionic gonadotropin, it's formulation and uses of the same - Google Patents

A composition comprising highly purified chorionic gonadotropin, it's formulation and uses of the same Download PDF

Info

Publication number
WO2012120535A3
WO2012120535A3 PCT/IN2012/000085 IN2012000085W WO2012120535A3 WO 2012120535 A3 WO2012120535 A3 WO 2012120535A3 IN 2012000085 W IN2012000085 W IN 2012000085W WO 2012120535 A3 WO2012120535 A3 WO 2012120535A3
Authority
WO
WIPO (PCT)
Prior art keywords
highly purified
composition
formulation
same
chorionic gonadotropin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2012/000085
Other languages
French (fr)
Other versions
WO2012120535A2 (en
Inventor
Prasad K.V.S.
L. Soman JAY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SANZYME Ltd
Original Assignee
SANZYME Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SANZYME Ltd filed Critical SANZYME Ltd
Publication of WO2012120535A2 publication Critical patent/WO2012120535A2/en
Publication of WO2012120535A3 publication Critical patent/WO2012120535A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention is directed to a composition comprising a low dose hCG in highly purified form intended for a novel application of promoting the estrogenic environment to support endometrial growth and receptivity and also the follicular growth with or without concomitant FSH preparation. The composition comprises highly purified hCG in the dose of 100 IU - 200 IU.
PCT/IN2012/000085 2011-02-03 2012-02-03 A composition comprising highly purified chorionic gonadotropin, it's formulation and uses of the same Ceased WO2012120535A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN315MU2011 2011-02-03
IN315/MUM/2011 2011-02-03

Publications (2)

Publication Number Publication Date
WO2012120535A2 WO2012120535A2 (en) 2012-09-13
WO2012120535A3 true WO2012120535A3 (en) 2013-03-14

Family

ID=46798607

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2012/000085 Ceased WO2012120535A2 (en) 2011-02-03 2012-02-03 A composition comprising highly purified chorionic gonadotropin, it's formulation and uses of the same

Country Status (1)

Country Link
WO (1) WO2012120535A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060217315A1 (en) * 2001-12-21 2006-09-28 Coelingh Bennink Herman J T Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
US7297777B2 (en) * 2000-02-22 2007-11-20 Laboratoires Serono Sa Process of purification of hCG and recombinant hCG purified by that method
US20080119394A1 (en) * 2003-06-03 2008-05-22 Ferring B.V. Unitary Combinations of FSH and hCG

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297777B2 (en) * 2000-02-22 2007-11-20 Laboratoires Serono Sa Process of purification of hCG and recombinant hCG purified by that method
US20060217315A1 (en) * 2001-12-21 2006-09-28 Coelingh Bennink Herman J T Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
US20080119394A1 (en) * 2003-06-03 2008-05-22 Ferring B.V. Unitary Combinations of FSH and hCG

Also Published As

Publication number Publication date
WO2012120535A2 (en) 2012-09-13

Similar Documents

Publication Publication Date Title
WO2012127501A3 (en) Composition for improving endometrial thickness during ovarian stimulation
MX2011007817A (en) Controlled release pharmaceutical or food formulation and process for its preparation.
BR112014003462A2 (en) personal care articles having multiple zones with malleable personal care compositions
WO2014066468A8 (en) Stable, low viscosity antibody formulation
WO2010000877A3 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
BR112014004460A2 (en) polymeric material for an insulated container
EP4219560A3 (en) Integrin alpha v beta 8 neutralizing antibody
AR086237A1 (en) FORMULATION FOR ANTIBODY ANTI-a4b7
WO2011160024A3 (en) Compounds useful as antiviral agents, compositions, and methods of use
EA033311B1 (en) Benzoxaborole derivatives as antibacterial agents
EP3626253A3 (en) Stable formulations of linaclotide
BR112012021337A8 (en) apixaban formulations.
BR112013020767A2 (en) compositions comprising alpha-ketocarboxylic peroxy acid and methods for the production and use thereof
WO2012051407A3 (en) Molecular containers and methods of making and using same
MX339060B (en) Factor viii formulations.
WO2011062437A3 (en) Gonadotropin releasing hormone receptor antagonists, manufacturing method thereof, and pharmaceutical composition containing same
GT200800117A (en) NEW ACICLIC FUROPIRIMIDINE DERIVATIVES SUBSTITUTED AND USE
NZ598518A (en) Concentrated polypeptide formulations with reduced viscosity
WO2011002422A3 (en) Solubility enhancing pharmaceutical formulation
CL2012003497A1 (en) Process for preparing the crystalline crystalline 3,6,9-triaza-3,6,9-tris (carboxymethyl) -4- (4-ethoxybenzyl) -undecanoic compound; its use to prepare a galenic formulation of the gadolinium complex of diacid 3,6,9-triaza-3,6,9-tris (carboxymethyl) -4- (4-ethoxybenzyl) -undecanoic; and the compound with a purity greater than 99%.
ECSP088472A (en) DERIVATIVES OF 9-CHLORINE-15-DEOXIPROSTAGLANDIN, PROCESSES FOR ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT
AU2012345659A8 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2012120535A3 (en) A composition comprising highly purified chorionic gonadotropin, it's formulation and uses of the same
BR112015015202A2 (en) composition
WO2011031099A3 (en) Ursodeoxycholic acid-synthetic hydrotalcite-eudragit hybrid, pharmaceutical composition containing the same and method for preparing the same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12755077

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12755077

Country of ref document: EP

Kind code of ref document: A2